Skip to main content
. 2018 Feb 22;9(20):15266–15274. doi: 10.18632/oncotarget.24555

Table 3. Detection of PIK3CA-H1047R and KRAS-G12D in cfDNA.

Sample number (n=29) PIK3CA-H1047R KRAS-G12D
Stage Tumor cfDNA (copies/ml) Tumor cfDNA (copies/ml)
OCCC1 III
OCCC2 I
OCCC3 I
OCCC4 I 0
OCCC5 I
OCCC6 I
OCCC8 III
OCCC10 III
OCCC11 II
OCCC12 I 0
OCCC13 IV 165
OCCC14 III 285
OCCC15 III
OCCC16 I
OCCC17 I 275
OCCC18 I
OCCC19 I
OCCC21 I 0
OCCC22 I
OCCC24 I
OCCC25 II 0*
OCCC26 I
OCCC27 I 0
OCCC31 I
OCCC33 I
OCCC34 III
OCCC35 I
OCCC36 I
OCCC37 II

*Although cfDNA was 0 at the initial diagnosis, cfDNA was detected during the course of disease.